Neurocrine Biosciences
Trading under the ticker NBIX, Neurocrine Biosciences is a technology and healthcare publicly traded company based in California. The company was founded in 1992 and is headquartered in California. It operates in the technology and healthcare sector. Its most recent annual filing reported revenue of about 2.9 billion dollars for fiscal 2025, per SEC 10-K filed 2026-02-11. These figures are factual reference only and are not investment advice. Facts on this page are drawn from public sources including SEC EDGAR, Wikidata, and the company's own disclosures, each linked below.
Company facts
| Headquarters | San Diego, California |
|---|---|
| Founded | 1992 |
| Type | public |
| Ticker | NBIX |
| Website | www.neurocrine.com/ |
Financials
$2.9B revenue for fiscal 2025 ($2,860,500,000).
| Fiscal year | Revenue | Source |
|---|---|---|
| 2025 | $2.9B | SEC 10-K filed 2026-02-11 |
| 2024 | $2.4B | SEC 10-K filed 2026-02-11 |
| 2023 | $1.9B | SEC 10-K filed 2026-02-11 |
| 2022 | $1.5B | SEC 10-K filed 2025-02-10 |
| 2021 | $1.1B | SEC 10-K filed 2024-02-09 |
Jobs at Neurocrine Biosciences
Search current openings at Neurocrine Biosciences →
This is an affiliate link to a third-party job board. See our disclosure.
Frequently asked questions
Where is Neurocrine Biosciences located?
Neurocrine Biosciences is based in San Diego, California.
When was Neurocrine Biosciences founded?
Neurocrine Biosciences was founded in 1992.
Is Neurocrine Biosciences publicly traded?
Yes. Neurocrine Biosciences is a public company trading under the ticker NBIX.
What industry is Neurocrine Biosciences in?
Neurocrine Biosciences operates in technology and healthcare.
Related companies
Sources
- Wikipedia (facts only; descriptions on this page are original)
- Wikidata Q7002174 (CC0)
- SEC EDGAR filings (public domain), CIK 0000914475